FINWIRES · TerminalLIVE
FINWIRES

$MLTX

2 stories mentioning MLTX

Every FINWIRES story that references MLTX, newest first.

Insider Trading

Moonlake Immunotherapeutics Insider Sold Shares Worth $2,752,163, According to a Recent SEC Filing

Jorge Santos Da Silva, Director, Chief Executive Officer, on April 10, 2026, sold 150,000 shares in Moonlake Immunotherapeutics (MLTX) for $2,752,163. Following the Form 4 filing with the SEC, Da Silva has control over a total of 2,924,893 Class A ordinary shares of the company, with 2,924,893 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1821586/000121390026043647/xslF345X05/ownership.xml

$MLTX
Insider Trading

Moonlake Immunotherapeutics Insider Sold Shares Worth $1,663,935, According to a Recent SEC Filing

Matthias Bodenstedt, Chief Financial Officer, on April 09, 2026, sold 87,795 shares in Moonlake Immunotherapeutics (MLTX) for $1,663,935. Following the Form 4 filing with the SEC, Bodenstedt has control over a total of 1,188,510 Class A ordinary shares of the company, with 1,188,510 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1821586/000121390026042629/xslF345X05/ownership.xml

$MLTX